|
KIAA0495 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.179300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.198600E-03 |
| Normal-vs-Stage2 |
5.472000E-01 |
| Normal-vs-Stage3 |
6.043800E-01 |
| Normal-vs-Stage4 |
4.506400E-02 |
| Stage1-vs-Stage2 |
3.405000E-01 |
| Stage1-vs-Stage3 |
2.869500E-02 |
| Stage1-vs-Stage4 |
2.002400E-02 |
| Stage2-vs-Stage3 |
4.033200E-01 |
| Stage2-vs-Stage4 |
9.454000E-02 |
| Stage3-vs-Stage4 |
4.398800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.744800E-03 |
| Normal-vs-AfricanAmerican |
9.946200E-02 |
| Normal-vs-Asian |
8.960300E-03 |
| Caucasian-vs-AfricanAmerican |
4.439600E-01 |
| Caucasian-vs-Asian |
3.315900E-02 |
| AfricanAmerican-vs-Asian |
2.702300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.500300E-03 |
| Normal-vs-Female |
9.766400E-02 |
| Male-vs-Female |
5.721200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.571400E-01 |
| Normal-vs-Extreme_Weight |
4.926400E-02 |
| Normal-vs-Obese |
3.871900E-02 |
| Normal-vs-Extreme_Obese |
7.236600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.677800E-01 |
| Normal_Weight-vs-Obese |
4.631400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.672600E-01 |
| Extreme_Weight-vs-Obese |
8.640000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.663400E-01 |
| Obese-vs-Extreme_Obese |
4.851800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.051800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.835550E-03 |
| Normal-vs-Age(61-80Yrs) |
3.260400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.865400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.727600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.136400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.152200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.259400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.846000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.348000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.04169999585125E-08 |
| Normal-VS-Type2 PRCC |
1.034450E-02 |
| Normal-VS-KIRP CIMP |
3.032100E-04 |
| Normal-VS-Unclassified PRCC |
1.760060E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.17683640610267E-14 |
| Type1 PRCC-VS-KIRP CIMP |
1.79858999999061E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.810600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.205010E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.78751999999616E-05 |
| KIRP CIMP-VS-Unclassified PRCC |
8.201000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.313800E-01 |
| Normal-vs-N1 |
4.285400E-01 |
| Normal-vs-N2 |
5.569900E-02 |
| N0-vs-N1 |
6.099800E-01 |
| N0-vs-N2 |
2.808800E-01 |
| N1-vs-N2 |
4.358800E-01 |
|
|
